Search

Your search keyword '"Nassif, Michael E."' showing total 14 results

Search Constraints

Start Over You searched for: Author "Nassif, Michael E." Remove constraint Author: "Nassif, Michael E." Topic sodium-glucose transporter 2 inhibitors Remove constraint Topic: sodium-glucose transporter 2 inhibitors
14 results on '"Nassif, Michael E."'

Search Results

1. Treatment effects of empagliflozin in hospitalized heart failure patients across the range of left ventricular ejection fraction - Results from the EMPULSE trial.

2. Implementing Sodium-Glucose Cotransporter-2 Inhibitor Therapy for Heart Failure: What Is the Message to DELIVER?

3. Renal effects of empagliflozin in patients hospitalized for acute heart failure: from the EMPULSE trial.

4. Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF.

5. The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial.

6. In-Hospital Initiation of Sodium-Glucose Cotransporter-2 Inhibitors for Heart Failure With Reduced Ejection Fraction.

7. The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial.

8. Empagliflozin Effects on Pulmonary Artery Pressure in Patients With Heart Failure: Results From the EMBRACE-HF Trial.

9. The elephant in the room: Why cardiologists should stop ignoring type 2 diabetes.

10. Effects of sodium glucose cotransporter type 2 inhibitors on heart failure.

12. Are We Ready to Bell The Cat? A Call for Cardiologists to Embrace Glucose-Lowering Therapies Proven to Improve Cardiovascular Outcomes.

13. Effect of Dapagliflozin on 6-Minute Walk Distance in Heart Failure With Preserved Ejection Fraction: PRESERVED-HF.

14. In-Hospital Initiation of Sodium-Glucose Cotransporter-2 Inhibitors for Heart Failure With Reduced Ejection Fraction

Catalog

Books, media, physical & digital resources